The INGUIDE Program is a comprehensive, evidence-based, and up-to-date training program for guideline recommendation and development. It is the product of a partnership between GIN and world-renowned experts in guideline research, development, and implementation at McMaster University’s Department of Health Research Methods, Evidence, and Impact. In addition, the program curriculum is developed by director of Cochrane Canada, Dr. Holger Schünemann, along with other active researchers from Cochrane Canada.
The program launched in September 2020 and is a professional certification program in guideline development and its mission is to improve the quality of practice guidelines globally, as well as reduce the amount of time and resources required to produce guidelines.
The INGUIDE training:
· Encompasses the entire guideline development process, including planning, implementation, evaluation and updating.
· Is based on comprehensive, evidence-based methodological research.
· Examines the guideline development processes of international agencies, professional societies, and expert experiences.
· Targets the required knowledge, skills and responsibilities of guideline panel members, methodologists, and chairs, as well as guideline development instructors.
The program is broken down into various levels.
· Level 1: Guideline Group or Panel Member Certification – designed for individuals participating as a member of a guideline development group
· Level 2: Guideline Methodologist Certification – designed for individuals participating in a guideline development group in the role of expert methodologist
· Level 3: Master Guideline Developer and Chair Certification – designed for individuals participating in a guideline development group in the role of chair or co-chair
· Level 4: Guideline Development Credentialing Instructor Certification – designed for individuals responsible for training prospective guideline development group members, methodologists, or chairs.
For more information about the INGUIDE Program, please visit: INGUIDE.org or contact email@example.com
Dr. Holger Schunemann, Director of Cochrane Canada, shares his thoughts in this video!